http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-202005878-U4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_216c9616e0c04a51993eda38fd2fad25 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate | 2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_435e6079a735d32975cd299a432835e1 |
| publicationDate | 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TR-202005878-U4 |
| titleOfInvention | THE SOLUTION TO REDUCE THE DEATH RATE IN COVID-19 PATIENTS |
| abstract | This invention is a solution to be applied when hope for the patient's condition is lost, who is infected with the corona virus, is in the intensive care unit, intubated and does not respond to the treatment applications. In this solution, the patient's vein is connected to the Ozone Therapy device, which washes the blood with ozone. An Ultraviolet UV-C light source is placed 15-20 cm (4) from the blood chamber of the ozone therapy device. The patient's blood is washed with ozone within a maximum of 20-25 minutes, to be determined by the doctor, and meanwhile, the patient's blood is purified from the corona virus with ultraviolet light in the 250-280 nm wavelength range. |
| priorityDate | 2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559478 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24823 |
Total number of triples: 14.